RT Journal
A1 Stancer HC, Quarrington BB, Cookson BA, Brown GM, Bonkalo AA, Lyall WL
T1 A longitudinal drug study and central amines
JF Archives of General Psychiatry
JO Archives of General Psychiatry
YR 1969
FD March 1
VO 20
IS 3
SP 290
OP 300
DO 10.1001/archpsyc.1969.01740150034006
UL http://dx.doi.org/10.1001/archpsyc.1969.01740150034006
AB BOTH SEROTONIN and norepinephrine are amines in the central nervous system which have been implicated in the production of psychiatric symptomatology. Behavioral changes were reported in schizophrenic patients who were given the serotonin precursor, tryptophan, with a monoamine oxidase inhibitor (MAOI).1-4 However, some of these studies also involved the use of methionine.3-5 Tryptophan has been shown to potentiate the antidepressant effects of MAOI in affective states.6,7 In contrast to these indole studies, the role of norepinephrine in affective states has been recently reviewed by Schildkraut,8 but there are as yet few supportive clinical studies.9-12Although some of the above studies were of longitudinal type, they were not conducted on patients with periodic illness. Furthermore, the interpretations of the importance of the drug actions were in terms of either serotonin or norepinephrine but not the combination. In this communication we